BRINTELLIX

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug BRINTELLIX contains one active pharmaceutical ingredient (API):

1	Vortioxetine UNII TKS641KOAY - VORTIOXETINE HYDROBROMIDE
	Vortioxetine is a 5-HT3, 5-HT7, and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and inhibitor of the 5-HT transporter, leading to modulation of neurotransmission in several systems, including predominantly the serotonin but probably also the norepinephrine, dopamine, histamine, acetylcholine, GABA and glutamate systems. This multimodal activity is considered responsible for the antidepressant and anxiolytic-like effects and the improvement of cognitive function, learning and memory observed with vortioxetine in animal studies.
	Read more about Vortioxetine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BRINTELLIX Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX26		N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	524216010002902, 524216010003002, 524216010003202, 524216010003302, 524216010003402, 524219050003902, 524219050004002, 524219050004102, 524220120005007
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	319-MEE-0514, 324-MEE-0614, 369-MEE-0614, 401-MEE-0714
EE	Ravimiamet	1637377, 1637388, 1637399, 1637401, 1637412, 1637423, 1637434, 1637445, 1637456, 1637467, 1637478, 1637489, 1637490, 1637502, 1637513, 1637524, 1637535, 1637546, 1637557, 1637568, 1637579, 1637580, 1637591, 1637603, 1637614, 1637625, 1637636, 1637647, 1637658, 1637726, 1674097, 1674132, 1674143
ES	Centro de información online de medicamentos de la AEMPS	113891002, 113891010, 113891019, 113891028, 113891036
FI	Lääkealan turvallisuus- ja kehittämiskeskus	025927, 088558, 136653, 172592, 194302, 402807, 495757, 499920
FR	Base de données publique des médicaments	60316362, 61439909, 62792157, 68562572
GB	Medicines & Healthcare Products Regulatory Agency	302476, 302479, 302482, 374311, 374313, 376222, 376224, 381219, 381221
HK	Department of Health Drug Office	63599, 63600, 63601
IE	Health Products Regulatory Authority	30110, 30123, 30258, 30307
IL	מִשְׂרַד הַבְּרִיאוּת	7724, 7725, 7726, 7727
LT	Valstybinė vaistų kontrolės tarnyba	1072508, 1072509, 1072510, 1072511, 1072512, 1072513, 1072514, 1072515, 1072516, 1072517, 1072518, 1072519, 1072520, 1072521, 1072522, 1072523, 1072524, 1072525, 1072526, 1072527, 1072528, 1072529, 1072530, 1072531, 1072532, 1072533, 1072534, 1072535, 1072536, 1072537, 1072538, 1072539, 1072540, 1072541, 1072542, 1072543, 1075155, 1075156, 1075157, 1075158
NL	Z-Index G-Standaard, PRK	120731, 120758, 120766, 120952
NZ	Medicines and Medical Devices Safety Authority	20574, 20575, 20576, 20577
PL	Rejestru Produktów Leczniczych	100317047, 100317337, 100317350, 100317366, 100317372
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60935001, W60998001, W60999001
SG	Health Sciences Authority	14665P, 14666P, 14667P
ZA	Health Products Regulatory Authority	48/1.2/0429, 48/1.2/0430, 48/1.2/0431, 48/1.2/0432